Clinical Trial Update: Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating beclomethasone dipropionate to prevent acute graft-versus-host disease in patients undergoing donor stem cell transplant for h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Cancer
• Hematopoietic Stem Cell Transplantation Related Complications

Drugs mentioned

• Beclomethasone Dipropionate (beclomethasone dipropionate)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED